首页 > 最新文献

Wiener Klinische Wochenschrift最新文献

英文 中文
Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma : A retrospective single center experience. 腹膜间皮瘤的细胞减少手术和腹腔内热化疗后的手术和肿瘤结果:回顾性单中心经验。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-21 DOI: 10.1007/s00508-024-02493-4
Muhammad Safwan, Ishwa Shakir, Saman Naz
{"title":"Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma : A retrospective single center experience.","authors":"Muhammad Safwan, Ishwa Shakir, Saman Naz","doi":"10.1007/s00508-024-02493-4","DOIUrl":"https://doi.org/10.1007/s00508-024-02493-4","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of 7-day mortality in critically ill patients with hyperglycemic crisis : A single center retrospective analysis. 高血糖危重症患者7天死亡率的预测因素:单中心回顾性分析
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-14 DOI: 10.1007/s00508-024-02489-0
Fabian Ruttinger, Christoph Schwarz, Georg-Christian Funk, Gregor Lindner, Roland Edlinger, Martin Auinger, Thomas Stulnig

Aim/hypothesis: The main aim of the study was to identify point of care available laboratory and clinical predictors of 7‑day mortality in critically ill patients with a hyperglycemic crisis.

Methods: A retrospective study of 990 patients with the first hospitalization due to hyperglycemia was performed. Patients were classified as having diabetic ketoacidosis (DKA) or being in a hyperosmolar hyperglycemic state (HHS) according to the recommendations of the American Diabetes Association (ADA). Patients not fulfilling the ADA criteria for DKA or HHS were summarized in a third group (unclassifiable hyperglycemia, UCH). The primary outcome was 7‑day mortality, potentially relevant factors were analyzed as secondary outcomes.

Results: Overall, the 7‑day mortality was 7.5%, with no significant differences between DKA (7.8%), HHS (14.5%) and UCH (6.1%). Blood lactate levels were significantly higher in nonsurvivors than survivors in all three groups (mean level of 6.3 mmol/l vs. 3.4 mmol/l in DKA, 5.3 mmol/l vs. 3.1 mmol/l in HHS, 5 mmol/l vs. 2.5 mmol/l in UCH). Measured and calculated osmolality were significantly higher in nonsurvivors in the DKA group (measured osmolality 359 mosmol/kg vs. 338 mosmol/kg, calculated osmolality 315 mosmol/kg vs. 305 mosmol/kg) and patients with UCH (354 mosmol/kg vs. 325 mosmol/kg; 315 mosmol/kg vs. 298 mosmol/kg) but not in patients with HHS. Survival analysis for the DKA group showed no significant differences in 7‑day mortality when patients were compared by the ADA criteria of severity (severe, moderate, or mild). Patients with elevated calculated osmolality (> 320 mosmol/kg) and lactate (> 4 mmol/l) had the lowest 7‑day survival rate (66.7%).

Conclusion/interpretation: Our data showed that elevated lactate levels were associated with higher mortality in all types of hyperglycemic crises.

目的/假设:本研究的主要目的是确定高血糖危象重症患者 7 天死亡率的护理点实验室和临床预测因素:对990名因高血糖首次住院的患者进行了回顾性研究。根据美国糖尿病协会(ADA)的建议,患者被划分为糖尿病酮症酸中毒(DKA)或高渗性高血糖状态(HHS)。不符合 ADA 标准的 DKA 或 HHS 患者被归入第三组(无法分类的高血糖,UCH)。主要结果是 7 天死亡率,潜在的相关因素作为次要结果进行分析:总体而言,7 天死亡率为 7.5%,DKA(7.8%)、HHS(14.5%)和 UCH(6.1%)之间无明显差异。在所有三组中,非存活者的血乳酸水平明显高于存活者(DKA 的平均水平为 6.3 毫摩尔/升,而存活者为 3.4 毫摩尔/升;HHS 的平均水平为 5.3 毫摩尔/升,而存活者为 3.1 毫摩尔/升;UCH 的平均水平为 5 毫摩尔/升,而存活者为 2.5 毫摩尔/升)。在 DKA 组(测量渗透压为 359 mosmol/kg vs. 338 mosmol/kg,计算渗透压为 315 mosmol/kg vs. 305 mosmol/kg)和 UCH 患者(测量渗透压为 354 mosmol/kg vs. 325 mosmol/kg;计算渗透压为 315 mosmol/kg vs. 298 mosmol/kg)中,非存活者的测量渗透压和计算渗透压均明显高于 HHS 患者。根据 ADA 的严重程度标准(重度、中度或轻度)对 DKA 组进行的生存分析表明,患者的 7 天死亡率没有显著差异。计算渗透压(> 320 mosmol/kg)和乳酸(> 4 mmol/l)升高的患者的 7 天存活率最低(66.7%):我们的数据显示,在所有类型的高血糖危象中,乳酸水平升高与死亡率升高有关。
{"title":"Predictors of 7-day mortality in critically ill patients with hyperglycemic crisis : A single center retrospective analysis.","authors":"Fabian Ruttinger, Christoph Schwarz, Georg-Christian Funk, Gregor Lindner, Roland Edlinger, Martin Auinger, Thomas Stulnig","doi":"10.1007/s00508-024-02489-0","DOIUrl":"https://doi.org/10.1007/s00508-024-02489-0","url":null,"abstract":"<p><strong>Aim/hypothesis: </strong>The main aim of the study was to identify point of care available laboratory and clinical predictors of 7‑day mortality in critically ill patients with a hyperglycemic crisis.</p><p><strong>Methods: </strong>A retrospective study of 990 patients with the first hospitalization due to hyperglycemia was performed. Patients were classified as having diabetic ketoacidosis (DKA) or being in a hyperosmolar hyperglycemic state (HHS) according to the recommendations of the American Diabetes Association (ADA). Patients not fulfilling the ADA criteria for DKA or HHS were summarized in a third group (unclassifiable hyperglycemia, UCH). The primary outcome was 7‑day mortality, potentially relevant factors were analyzed as secondary outcomes.</p><p><strong>Results: </strong>Overall, the 7‑day mortality was 7.5%, with no significant differences between DKA (7.8%), HHS (14.5%) and UCH (6.1%). Blood lactate levels were significantly higher in nonsurvivors than survivors in all three groups (mean level of 6.3 mmol/l vs. 3.4 mmol/l in DKA, 5.3 mmol/l vs. 3.1 mmol/l in HHS, 5 mmol/l vs. 2.5 mmol/l in UCH). Measured and calculated osmolality were significantly higher in nonsurvivors in the DKA group (measured osmolality 359 mosmol/kg vs. 338 mosmol/kg, calculated osmolality 315 mosmol/kg vs. 305 mosmol/kg) and patients with UCH (354 mosmol/kg vs. 325 mosmol/kg; 315 mosmol/kg vs. 298 mosmol/kg) but not in patients with HHS. Survival analysis for the DKA group showed no significant differences in 7‑day mortality when patients were compared by the ADA criteria of severity (severe, moderate, or mild). Patients with elevated calculated osmolality (> 320 mosmol/kg) and lactate (> 4 mmol/l) had the lowest 7‑day survival rate (66.7%).</p><p><strong>Conclusion/interpretation: </strong>Our data showed that elevated lactate levels were associated with higher mortality in all types of hyperglycemic crises.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142984549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In memoriam Univ.-Prof. Dr. Fritz Sterz (1956-2024) : A life dedicated to saving lives. 纪念大学-教授。弗里茨·斯特兹博士(1956-2024):一生致力于拯救生命。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-08 DOI: 10.1007/s00508-024-02495-2
Wilhelm Behringer
{"title":"In memoriam Univ.-Prof. Dr. Fritz Sterz (1956-2024) : A life dedicated to saving lives.","authors":"Wilhelm Behringer","doi":"10.1007/s00508-024-02495-2","DOIUrl":"https://doi.org/10.1007/s00508-024-02495-2","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comic that explains palliative care: how patients experience comic-based educational material. 解释姑息治疗的漫画:病人如何体验基于漫画的教育材料。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-07 DOI: 10.1007/s00508-024-02480-9
Anna Kitta, Sarah Winsauer, Sal Marx, Lea Kum, Feroniki Adamidis, Franziska Ecker, Jessica Stöger, Eva Katharina Masel

Objective: The aim of this study was to create a patient-centered comic on palliative care with and for patients admitted to a palliative care unit and to examine their experiences of graphic educational material.

Methods: This study employed a qualitative methodology using semi-structured interviews with advanced cancer patients admitted to the palliative care unit of the Medical University of Vienna. The data were analyzed using thematic analysis with the assistance of the MAXQDA software.

Results: In the first phase of the comic creation 6 interviews were conducted and 15 additional interviews in the second phase, all of which examined patients' reactions to the comic. The findings revealed three themes: 1) patients' experiences with and understanding of graphics about palliative care, 2) patients' perceptions of the possibilities for use of the comic and 3) how the visual material facilitated access to the patients' shared imagination and interpretations. The medium generated curiosity, participation, and positive reactions. Patients were inclined to be involved in patient-centered educational material that enabled an entry into conversations and connection, giving access to feelings and associations of patients.

Conclusion: The results of the present study offer insights into mostly positive reactions of patients when presented with a comic about palliative care. The study showed how illustrated educational information led to deepened conversation among the interviewer and the patients, offering insights into their experiences and imagination.

目的:本研究的目的是创建一个以病人为中心的漫画姑息治疗与患者入院姑息治疗单位,并检查他们的经验图形教育材料。方法:本研究采用半结构化访谈的定性方法,对维也纳医科大学姑息治疗部门收治的晚期癌症患者进行访谈。利用MAXQDA软件对数据进行专题分析。结果:在漫画创作的第一阶段进行了6次访谈,第二阶段进行了15次访谈,所有访谈都检查了患者对漫画的反应。研究结果揭示了三个主题:1)患者对姑息治疗图形的体验和理解;2)患者对漫画使用可能性的看法;3)视觉材料如何促进患者共同的想象和解释。这种媒介产生了好奇心、参与性和积极的反应。患者倾向于参与以患者为中心的教育材料,使他们能够进入对话和联系,从而获得患者的感受和联系。结论:本研究的结果提供了见解,大多数积极的反应的病人,当提出关于姑息治疗的漫画。该研究表明,有插图的教育信息如何使采访者和患者之间的对话更加深入,从而深入了解他们的经历和想象。
{"title":"A comic that explains palliative care: how patients experience comic-based educational material.","authors":"Anna Kitta, Sarah Winsauer, Sal Marx, Lea Kum, Feroniki Adamidis, Franziska Ecker, Jessica Stöger, Eva Katharina Masel","doi":"10.1007/s00508-024-02480-9","DOIUrl":"https://doi.org/10.1007/s00508-024-02480-9","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to create a patient-centered comic on palliative care with and for patients admitted to a palliative care unit and to examine their experiences of graphic educational material.</p><p><strong>Methods: </strong>This study employed a qualitative methodology using semi-structured interviews with advanced cancer patients admitted to the palliative care unit of the Medical University of Vienna. The data were analyzed using thematic analysis with the assistance of the MAXQDA software.</p><p><strong>Results: </strong>In the first phase of the comic creation 6 interviews were conducted and 15 additional interviews in the second phase, all of which examined patients' reactions to the comic. The findings revealed three themes: 1) patients' experiences with and understanding of graphics about palliative care, 2) patients' perceptions of the possibilities for use of the comic and 3) how the visual material facilitated access to the patients' shared imagination and interpretations. The medium generated curiosity, participation, and positive reactions. Patients were inclined to be involved in patient-centered educational material that enabled an entry into conversations and connection, giving access to feelings and associations of patients.</p><p><strong>Conclusion: </strong>The results of the present study offer insights into mostly positive reactions of patients when presented with a comic about palliative care. The study showed how illustrated educational information led to deepened conversation among the interviewer and the patients, offering insights into their experiences and imagination.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MUW researcher of the month. 本月MUW研究员。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 DOI: 10.1007/s00508-024-02494-3
{"title":"MUW researcher of the month.","authors":"","doi":"10.1007/s00508-024-02494-3","DOIUrl":"https://doi.org/10.1007/s00508-024-02494-3","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":"137 1-2","pages":"64-65"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life? 对于生命最初二十年的脑膜瘤患者的长期临床预后而言,位置是否比世卫组织分级更具决定性?
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-05-31 DOI: 10.1007/s00508-024-02382-w
Dorian Hirschmann, Danial Nasiri, Christian Joachim Entenmann, Christine Haberler, Thomas Roetzer, Christian Dorfer, Matthias Millesi

Objective: To identify factors for tumor relapse and poor outcome in patients with meningiomas in the first two decades of life.

Methods: All patients ≤ 21 years of age who underwent resection of a meningioma at the department of neurosurgery, Medical University of Vienna between 1989 and 2022 were included in this retrospective study. Clinical and radiological data were extracted from the medical records. Outcome and tumor relapse were analyzed for tumor location, histological findings and extent of resection.

Results: In this study 18 patients were included, 6 meningiomas were located in the skull base, 5 in the convexity and 7 in other locations including intraventricular and spine (2 patients each), falx, intraparenchymal and optic nerve sheath. Most frequent symptoms were seizures and cranial nerve palsy. In total 56% of the meningiomas were World Health organization (WHO) grade 1, 39% grade 2 and 5% grade 3. Gross total resection was achieved in 67%. The overall relapse rate was 61% and 50% underwent repeat surgery. All patients with convexity meningiomas became seizure free and had a favorable outcome. Relapse and clinical outcome were independent of WHO grade among the whole cohort but the outcome significantly depended on the WHO grade when patients with skull base meningiomas were analyzed as a subgroup. The relapse rate was significantly higher in cases of skull base location (100% vs. 42%, p = 0.038) and after subtotal resection (100% vs. 42%, p = 0.038). Clinical outcome was also significantly worse and the rate of complications was higher in patients with skull base meningiomas.

Conclusion: Patients with convexity meningiomas in the first two decades of life have a good outcome due to high chance of gross total resection. Patients with skull base meningioma are at high risk of relapse and poor outcome, particularly those with WHO grades 2 and 3. Subtotal resection in patients with skull base location is probably the main reason for this difference.

摘要确定头二十年脑膜瘤患者肿瘤复发和预后不良的因素:这项回顾性研究纳入了1989年至2022年期间在维也纳医科大学神经外科接受脑膜瘤切除术的所有年龄小于21岁的患者。研究人员从病历中提取了临床和放射学数据。根据肿瘤位置、组织学结果和切除范围分析了治疗结果和肿瘤复发情况:本研究共纳入18例患者,其中6例脑膜瘤位于颅底,5例位于凸面,7例位于其他部位,包括脑室内和脊柱(各2例)、镰状脑膜瘤、实质内脑膜瘤和视神经鞘。最常见的症状是癫痫发作和颅神经麻痹。56%的脑膜瘤为世界卫生组织(WHO)1级,39%为2级,5%为3级。67%的脑膜瘤实现了全切除。总复发率为61%,50%的患者接受了再次手术。所有凸面脑膜瘤患者均无癫痫发作,预后良好。在整个组别中,复发率和临床预后与WHO分级无关,但将颅底脑膜瘤患者作为一个亚组进行分析时,预后则明显取决于WHO分级。颅底脑膜瘤的复发率明显更高(100% 对 42%,P = 0.038),次全切除术后的复发率也更高(100% 对 42%,P = 0.038)。颅底脑膜瘤患者的临床预后也明显较差,并发症发生率较高:结论:生命最初二十年的凸面脑膜瘤患者由于大体全切除的几率高,因此预后良好。颅底脑膜瘤患者复发风险高,预后差,尤其是WHO分级为2级和3级的患者。颅底脑膜瘤患者的次全切除术可能是造成这种差异的主要原因。
{"title":"Is location more determining than WHO grade for long-term clinical outcome in patients with meningioma in the first two decades of life?","authors":"Dorian Hirschmann, Danial Nasiri, Christian Joachim Entenmann, Christine Haberler, Thomas Roetzer, Christian Dorfer, Matthias Millesi","doi":"10.1007/s00508-024-02382-w","DOIUrl":"10.1007/s00508-024-02382-w","url":null,"abstract":"<p><strong>Objective: </strong>To identify factors for tumor relapse and poor outcome in patients with meningiomas in the first two decades of life.</p><p><strong>Methods: </strong>All patients ≤ 21 years of age who underwent resection of a meningioma at the department of neurosurgery, Medical University of Vienna between 1989 and 2022 were included in this retrospective study. Clinical and radiological data were extracted from the medical records. Outcome and tumor relapse were analyzed for tumor location, histological findings and extent of resection.</p><p><strong>Results: </strong>In this study 18 patients were included, 6 meningiomas were located in the skull base, 5 in the convexity and 7 in other locations including intraventricular and spine (2 patients each), falx, intraparenchymal and optic nerve sheath. Most frequent symptoms were seizures and cranial nerve palsy. In total 56% of the meningiomas were World Health organization (WHO) grade 1, 39% grade 2 and 5% grade 3. Gross total resection was achieved in 67%. The overall relapse rate was 61% and 50% underwent repeat surgery. All patients with convexity meningiomas became seizure free and had a favorable outcome. Relapse and clinical outcome were independent of WHO grade among the whole cohort but the outcome significantly depended on the WHO grade when patients with skull base meningiomas were analyzed as a subgroup. The relapse rate was significantly higher in cases of skull base location (100% vs. 42%, p = 0.038) and after subtotal resection (100% vs. 42%, p = 0.038). Clinical outcome was also significantly worse and the rate of complications was higher in patients with skull base meningiomas.</p><p><strong>Conclusion: </strong>Patients with convexity meningiomas in the first two decades of life have a good outcome due to high chance of gross total resection. Patients with skull base meningioma are at high risk of relapse and poor outcome, particularly those with WHO grades 2 and 3. Subtotal resection in patients with skull base location is probably the main reason for this difference.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"21-30"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141180917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
12. Pneumo Aktuell.
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 DOI: 10.1007/s00508-024-02492-5
{"title":"12. Pneumo Aktuell.","authors":"","doi":"10.1007/s00508-024-02492-5","DOIUrl":"https://doi.org/10.1007/s00508-024-02492-5","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":"137 1-2","pages":"66"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143012519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited. 眼睑基底细胞癌手术切除后的长期效果:再探。
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-02-13 DOI: 10.1007/s00508-024-02333-5
Reinhard Told, Adrian Reumueller, Judith Kreminger, Birgit Lackner, Andreas Kuchar, Ursula Schmidt-Erfurth, Roman Dunavoelgyi

The aim of the study was to readdress basal cell carcinoma (BCC) in the periocular region to prove the efficacy of histologically controlled surgical treatment and to identify high-risk characteristics.Retrospective analysis of 451 microscopically controlled BCC excisions in the periocular region. Tumor location, tumor size, AJCC 7 classification, and histological results were recorded. The same procedure was followed for recurrences.A recurrence rate of 5.0% was observed after the first microscopically controlled excision. Recurrent BCCs show a shift from nodular to sclerosing BCC as the primary histological type as well as a change in primary location from lower eyelid to medial canthus. The frequency of BCC with deep extension increased from 7.3% to 24.7%, and 57.1% after the second and third operations, respectively. The recurrence rate increased to 9.5% and 42.9%, after the second and third operations, respectively.In conclusion, we are facing the same challenges in surgical BCC treatment as 30 years ago. The distribution of periocular BCC location, histologic subtype and recurrence rates mirror the literature und the general consensus. The recurrence rate increases with every operation needed. Sclerosing BCCs with deep extension at the medial canthus bear the greatest risk for recurrence. In such cases, centers of expertise should be consulted and additional treatment options should be considered.

该研究旨在重新研究眼周基底细胞癌(BCC),以证明组织学控制手术治疗的有效性,并确定高风险特征。记录了肿瘤位置、肿瘤大小、AJCC 7分类和组织学结果。首次显微镜下控制切除术后的复发率为 5.0%。复发 BCC 的主要组织学类型从结节型 BCC 变为硬化型 BCC,原发部位也从下眼睑变为内眼角。第二次和第三次手术后,BCC向深部扩展的频率分别从7.3%增至24.7%和57.1%。总之,我们在 BCC 手术治疗方面面临着与 30 年前相同的挑战。眼周 BCC 的位置分布、组织学亚型和复发率反映了文献和普遍共识。每进行一次手术,复发率就会增加一次。硬化性 BCC 在内侧眦部有深度扩展,复发风险最大。在这种情况下,应咨询专业中心,并考虑其他治疗方案。
{"title":"Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited.","authors":"Reinhard Told, Adrian Reumueller, Judith Kreminger, Birgit Lackner, Andreas Kuchar, Ursula Schmidt-Erfurth, Roman Dunavoelgyi","doi":"10.1007/s00508-024-02333-5","DOIUrl":"10.1007/s00508-024-02333-5","url":null,"abstract":"<p><p>The aim of the study was to readdress basal cell carcinoma (BCC) in the periocular region to prove the efficacy of histologically controlled surgical treatment and to identify high-risk characteristics.Retrospective analysis of 451 microscopically controlled BCC excisions in the periocular region. Tumor location, tumor size, AJCC 7 classification, and histological results were recorded. The same procedure was followed for recurrences.A recurrence rate of 5.0% was observed after the first microscopically controlled excision. Recurrent BCCs show a shift from nodular to sclerosing BCC as the primary histological type as well as a change in primary location from lower eyelid to medial canthus. The frequency of BCC with deep extension increased from 7.3% to 24.7%, and 57.1% after the second and third operations, respectively. The recurrence rate increased to 9.5% and 42.9%, after the second and third operations, respectively.In conclusion, we are facing the same challenges in surgical BCC treatment as 30 years ago. The distribution of periocular BCC location, histologic subtype and recurrence rates mirror the literature und the general consensus. The recurrence rate increases with every operation needed. Sclerosing BCCs with deep extension at the medial canthus bear the greatest risk for recurrence. In such cases, centers of expertise should be consulted and additional treatment options should be considered.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"7-12"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of fecal incontinence-is there a light in the end of the tunnel? 治疗大便失禁--隧道尽头是否有曙光?
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-05-07 DOI: 10.1007/s00508-024-02369-7
Stefan Riss, Christopher Dawoud

Fecal incontinence (FI) is a common disease with higher incidence rates in the elderly population. Treatment of affected patients remains challenging and ranges from conservative management to surgical techniques. Despite all efforts patients often undergo several therapeutic measurements to achieve reasonable functional improvements.Although sacral neuromodulation still remains a key therapy with success rates up to 80%, a significant number of patients do not respond sufficiently and require further treatment.Several artificial bowel sphincter devices exist, which can lead to better functional control in selected patients. Notably, complications after these surgeries do occur frequently and the need for implant replacement is still considerable high.A novel anal band, developed by Agency for Medical Innovations (A.M.I., Austria) is currently under evaluation. This device, composed of silicone and polyester, is placed around the anus outside the external sphincter muscle complex aiming to improve stool continence via mechanical pressure. Early results of this new operation are eagerly awaited.

大便失禁(FI)是一种常见疾病,在老年人群中发病率较高。对患者的治疗仍然具有挑战性,从保守治疗到外科技术,不一而足。尽管骶神经调控仍是一种重要的治疗方法,成功率高达 80%,但仍有相当数量的患者反应不佳,需要进一步治疗。值得注意的是,这些手术后的并发症确实经常发生,而且植入物更换的需求仍然相当高。这种由硅胶和聚酯组成的装置被放置在外括约肌复合体外的肛门周围,旨在通过机械压力改善大便的连续性。我们翘首以盼这一新手术的早期结果。
{"title":"Treatment of fecal incontinence-is there a light in the end of the tunnel?","authors":"Stefan Riss, Christopher Dawoud","doi":"10.1007/s00508-024-02369-7","DOIUrl":"10.1007/s00508-024-02369-7","url":null,"abstract":"<p><p>Fecal incontinence (FI) is a common disease with higher incidence rates in the elderly population. Treatment of affected patients remains challenging and ranges from conservative management to surgical techniques. Despite all efforts patients often undergo several therapeutic measurements to achieve reasonable functional improvements.Although sacral neuromodulation still remains a key therapy with success rates up to 80%, a significant number of patients do not respond sufficiently and require further treatment.Several artificial bowel sphincter devices exist, which can lead to better functional control in selected patients. Notably, complications after these surgeries do occur frequently and the need for implant replacement is still considerable high.A novel anal band, developed by Agency for Medical Innovations (A.M.I., Austria) is currently under evaluation. This device, composed of silicone and polyester, is placed around the anus outside the external sphincter muscle complex aiming to improve stool continence via mechanical pressure. Early results of this new operation are eagerly awaited.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"56-57"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency-A prospective controlled open-label trial: correspondence. 先天性免疫缺陷(IEI)或甘露糖结合凝集素(MBL)缺乏症患者对第三次COVID-19疫苗接种的体液和细胞反应——一项前瞻性对照开放标签试验:通信
IF 1.9 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 Epub Date: 2024-12-11 DOI: 10.1007/s00508-024-02482-7
Matthias G Vossen, Lisa Göschl
{"title":"Response to letter regarding article, humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity (IEI) or mannan-binding lectin (MBL) deficiency-A prospective controlled open-label trial: correspondence.","authors":"Matthias G Vossen, Lisa Göschl","doi":"10.1007/s00508-024-02482-7","DOIUrl":"10.1007/s00508-024-02482-7","url":null,"abstract":"","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":" ","pages":"60-61"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Wiener Klinische Wochenschrift
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1